DETAILED NOTES ON COPYRIGHT DERIVATIVES

Understanding OUR Cytokine-Based Immunotherapy Candidates Our motivation extends to advancing a robust portfolio of programs aimed at increasing the horizons of cytokine-based immunotherapy, specifically for cancers where cure options remain limited. Make use of the links below to learn additional about our portfolio of cytokine-based immunotherapy